4/A

PRIMARY DOCUMENT

Company: ELITE PHARMACEUTICALS INC /NV/
Filed: March 20, 2012
Period of Report: January 18, 2011
Accession Number: 0001345568-12-000006

View Document ↗ View on SEC.gov ↗